Improve your exploratory development and phase I clinical trials

Exploratory Clinical Development World Europe has established itself as the largest and most influential European event for top pharmaceutical and biotechnology representatives working within exploratory development and early phase clinical trials.
 

For delegates
The 3rd annual Exploratory Clinical Development World Europe 2009 was a great success with unprecedented attendance from professionals working in exploratory clinical development / early phase trials in the pharmaceutical and biotechnology industry. This year we have double the content, double the speakers and double the networking opportunities. This year we are on track to attract a record number of attendees from leading pharmaceutical and biotechnology companies plus delegates working in academia, technology companies, clinical research organisations, government bodies and consultants.

» Reserve your seat now
» Check out the programme
» Find out more about submitting a poster

 

 

Follow our updates

Meet and network with the World's early clinical development leaders

2009 delegate feedback
The feedback received provided an excellent grounding as we begun work on the 2010 event and with all the attendees rating it as good and excellent we are bound to see a high delegate retention rate. The hot topics for 2010 include:

- Organisational models to support R&D
- Building clinical confidence in basic molecule
properties
-Review of policy initiatives driving innovation in
early development
- Fast tracking to proof of concept
- Can Bayesian probability help predict trial
outcomes?
-Minimising risk in the transition between preclinical and first in man studies
- Regulatory status review for first-in-man trials
- How do you develop biomarkers to the status
of true surrogates and what are the possibilities
- Design considerations/preclinical safety testing requirements for safety pharmacology studies
-Mechanism-based PK/PD modelling and simulation
-Biomarker qualification strategies and assessment on ROI

» Take a look at this year's programme
» Register for this year's event

Whats new in 2010
Learn from these real life experiences
 
-What role can exploratory clinical trials play in early clinical development? Are you planning to fail or to win and can they help pipeline attrition?
AstraZeneca’s Dr Lewis Kinter will discuss the latest options as per ICH M3 (R2) and
industry’s experience with eCTAs.

-The IMI has recently launched its second call
for research proposals. What are the lessons
learnt and the way forward to rescue pharma’s
floundering R&D model?
Professor, Dr Michael
Goldman provides feedback from the IMI
.

-How is the role of the clinical pharmacologist
changing?
Dr John Davis, Senior Director
Clinical Pharmacology, Pfizer
will discuss the
clinical pharmacologist’s role and how quantitative techniques are being used to meet new challenges in drug development and discovery.
 

» See full speaker list
» Register for this year's event

register today
Why should you sponsor this event?
 

Join the exhibition - book early for optimum stand placement!

Exploratory Clinical Development World will bring together leaders, decision makers and influencers in early clinical research & development. Our delegates will be looking for guidance, answers, and new business relationships, representing a significant and exceptional business opportunity.

The event will offer a variety of conference and networking formats including; workshops, plenary sessions, streamed sessions, breakfast briefing, evening seminar, speed networking, online contact system and a sociable drinks reception. All refreshments and breaks will take place in the exhibition area, giving you maximum opportunity to mix with the attendees.

Eighteen sponsors and exhibitors participated in the event and all left quoting a positive experience. The event has been rated as excellent or good by everyone and most of 2009 sponsors are returning this year.

» Find out more
» Looking for an event taking place sooner or in a different part of the world?

 

 
 

our speakers
Speaker photo
Baroness Susan Greenfield
CBE, Director
Royal Institution
Speaker photo
Dr Eckhard von Keutz
SVP, Head Global Early Development
Bayer Schering Pharma AG
Speaker photo
Dr Jackie Hunter
SVP Science Environment Development
GlaxoSmithKline
Speaker photo
Professor Dr Michel Goldman
Executive Director
Innovative Medicines Initiative
Speaker photo
Dr John Davis
Senior Director, Group Head Research Clinical Pharmacology
Pfizer
 

conference details
Conference:
Pre-conference workshop
18 May 9am - 5pm
Day 1
19 May 8:30am - 6:30pm
Day 2
20 May 8:30am - 5:30pm
Post-conference workshop
21 May 9am - 5pm
 
Venue:
Hotel Sofitel London Heathrow, London, United Kingdom

› Add this to my calendar

Register online now
or call +44 (0) 207 608 7055

 

 
Contact LIVE
share

event sponsors
Premium sponsor:
 
 
Breakfast briefing host:
 
Media Partners:
 
 

 
 

Follow us on Twitter
Twitter logo

› follow us! › tweet this!